Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lumecare Eyelid Wipes are sterile, single-use, pre-moistened topical wipes designed for daily eyelid and eyelash hygiene. Developed by Medicom Healthcare with input from experts in Meibomian Gland Dysfunction (MGD), these preservative-free and detergent-free wipes are formulated with a physiological electrolyte solution consisting of sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate, sodium citrate dihydrate, and purified water. They function by physically cleansing the eyelids and eyelashes to remove oily debris, crusting, pollen, and other contaminants, helping to manage symptoms of blepharitis, dry eye, and meibomian gland dysfunction. The wipes are suitable for adults, children, and babies, including those with sensitive skin or eyes, and do not require rinsing after use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lumecare Eyelid Wipes.